Savings Effect

Interarch Building Solutions shares plunge 17%, most on record, after Q4 profit falls

SONA BLW: SC GIVES RELEIF TO RANI KAPUR IN SONA BLW CASE FAMILY DISPUTE

IRAN'S FOREIGN MINISTER: TEHRAN CALLS ON BRICS MEMBERS TO UNEQUIVOCALLY CONDEMN U.S. AND ISRAEL AGGRESSION AGAINST IRAN - STATEMENT

KOTYARK INDUSTRIES: CO APPROVES BONUS IN RATIO OF 10:1

Rupee Hits Record Low Of 95.91 Against US Dollar

SEBI SAYS PAPER ON MEASURES FOR EASE OF DOING BUSINESS ON EXCHANGE TRADED DERIVATIVES

INDOCO REMEDIES: CO FACILITY HAS RECEIVED EU GMP CERTIFICATION FROM THE MALTA MEDICINES AUTHORITY CONFIRMING THAT THE FACILITY COMPLIES WITH THE GOOD MANUFACTURING PRACTICE REQUIREMENTS AS REFERRED IN THE EC DIRECTIVE.

HFCL IN FOCUS CO APPROVED THE ESTABLISHMENT OF A DEFENCE MANUFACTURING FACILITY FOR MANUFACTURE OF MULTI-MODE HAND GRENADE (MMHG) AND SIMILAR OTHER PRODUCTS IN ANDHRA PRADESH (“DEFENCE FACILITY; TOTAL CAPITAL OUTLAY OF 230 CR RS

The duty hike is expected to make bullion imports costlier, pushing up jewellery prices and investment demand. Analysts warn it could revive smuggling, while others see opportunities for investors. This could push domestic gold prices even higher, regardless of global price trends.

SIEMENS GLOBAL SAYS INDIA REVENUE GREW 21% — FAR ABOVE STREET ESTIMATES OF 6-7% STRONG SIGNAL THAT INDIA CAPEX DEMAND REMAINS ROBUST ACROSS INDUSTRY, INFRA & ELECTRIFICATION MANAGEMENT VERY POSITIVE ON INDIA GROWTH OUTLOOK GOING FORWARD

TRUMP ARRIVES AT TEMPLE OF HEAVEN IN CHINA

Chinese President: American companies will have broader prospects in China

KAYNES TECH: CO’S FOCUS ON THE SEMICONDUCTOR OSAT FACILITY REPRESENTS A MAJOR STRATEGIC SHIFT TOWARD HIGH-MARGIN BUSINESS. INVESTORS ARE CLOSELY MONITORING THE RS.28B INVESTMENT PLAN, AS SUCCESSFUL EXECUTION IN 2027 COULD FUNDAMENTALLY RE-RATE THE STOCK FROM A PURE-PLAY EMS PROVIDER TO A SEMICONDUCTOR PLAYER. - CONCALL UPDATE

XI: CHINA'S DOORS WILL OPEN MORE

AlembicPharma receives US FDA tentative approval for Darolutamide tablets, 300 mg Alert: #Darolutamide is an oral medication used to treat specific types of advanced prostate cancer Alert: Darolutamide has an estimated market size of $3,155 m for 12 months ending March 2026

ALEMBIC PHARMACEUTICALS: CO. RECEIVES USFDA TENTATIVE APPROVAL FOR DAROLUTAMIDE TABLETS, 300 MG; THERAPEUTICALLY EQUIVALENT TO NUBEQA TABLETS; ESTIMATED MARKET SIZE OF US$ 3 BLN

METROPOLIS HEALTHCARE: MANAGEMENT CONFIRMED A BULLISH 13-15% GROWTH TARGET FOR 2027, DESPITE THE Q4 MISS - CONCALL UPDATE

JANA SMALL FINANCE: TVS GROUP SET TO BUY STAKE IN CO

Chinese President warns of conflict between Beijing and Washington if Taiwan issue is mishandled